Japan’s Shionogi, AstraZeneca Sue Seven Generics For Violating Crestor Patent (Japan)
This article was originally published in PharmAsia News
Executive Summary
Japan's Shionogi joined with AstraZeneca in suing seven makers of generic drugs for applying in the United States for a version of Crestor (rosuvastatin calcium) for lowering cholesterol. Shionogi, the developer, said its U.S. patent for the drug is still in effect and the application violates it. AstraZeneca markets the drug. Defendants in the suit are Apotex, Aurobindo Pharma, Cobalt Pharmaceuticals, Mylan Pharmaceuticals, Pan Pharmaceuticals, Sandoz and Sun Pharmaceuticals. (Click here for more - may require a subscription